¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2021 ´ëÇѺñ°úÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-07-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2021 ´ëÇѺñ°úÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-07-25
±³À°ÀÏÀÚ : 2021-07-25
±³À°Àå¼Ò : ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ  
±³À°ÁÖÁ¦ : 2021 ´ëÇѺñ°úÇÐȸ Çмú½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѺñ°úÇÐȸ
´ã´çÀÚ : ±èµ¿¿µ
¿¬¶ôó : 02-3461-9945  
À̸ÞÀÏ : rhino@ksrhino.or.kr      
±³À°Á¾·ù : À̺ñÀÎÈÄ°ú      
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 12 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 160,000¿ø      
ºñ°í ¿¬È¸ºñ ³³ºÎ ȸ¿ø 50,000¿ø / À̺ñÀÎÈÄ°ú Àü¹®ÀÇ 80,000¿ø / Àü°øÀÇ 20,000¿ø / À̺ñÀÎÈÄ°ú ¿Ü Àü¹®ÀÇ 160,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 08:40~09:05 Experience and perspectives of biologics in CRS  Joseph Han(Eastern Virginia Medical School, USA) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 09:05~09:30 Lessons from allergic asthma: Biomarkers for responder and patient care  ±è»óÇö(ÇѾç´ë È£Èí±â¾Ë·¹¸£±â³»°ú) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 09:30~09:55 Lessons from dermatologic diseases : Biomarkers for responder and patient care  Àå¿ëÇö(°æºÏ´ë ÇǺΰú) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 09:55~10:20 Personalized medicine in biologics for CRS: Known and Unknown  ¹ÎÁø¿µ(°æÈñ´ë) 
È޽Ġ07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 10:20~10:40 Coffee Break  () 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 10:40~11:00 Endoscopic nasopharyngectomy and postoperative management  ¿øźó(¼­¿ï´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 11:00~11:20 Endoscopic transrobital approach  Darlene E Lubbe(University of Cape Town,South Africa) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 11:20~11:40 How far we can go endoscopically-Aspect from Rhinologist  Kazuhiro Omura(Jikei university, Japan) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 11:40~12:00 How far we can go endoscopically-Aspect from Neurosurgeon  È«Ã¢±â(¿ï»ê´ë ½Å°æ¿Ü°ú) 
½Ä»ç 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 12:00~12:30 Luncheon symposium  () 
½Ä»ç 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 12:30~13:30 Lunch  () 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 13:30~13:55 Á¤¹ÐÀǷḦ À§ÇÑ È¯ÀÚ ÀÇ·á µ¥ÀÌÅÍ¿Í ¸ÖƼ¿À¹Í½º µ¥ÀÌÅÍÀÇ »ý¹°Á¤º¸ÇÐ ±â¹Ý ÅëÇÕ Àü·«  ±è»ó¿í(Æ÷Ç×°ø´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 13:55~14:20 Recent advances in Omics and human cell atlas  ¹ÚÁ¾Àº(KAIST) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 14:20~14:45 ÀΰøÁö´ÉÀ» È°¿ëÇÑ ºòµ¥ÀÌÅÍ ±â¹Ý ½Å¾à±â¼ú°³¹ß µ¿Çâ  ±ÇÁø¼±(¾ÖÀÓ½º¹ÙÀÌ¿À»çÀ̾ð½º) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 14:45~15:10 Multilayered omics  Mikael Benson(Linköping University, Sweden) 
±âŸ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 15:10~15:20 Á¤±âÃÑȸ  () 
È޽Ġ07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 15:20~15:40 Coffee Break  () 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 15:40~16:00 Radiotherapy strategies according to histology and staging-Aspect from Radiation Oncologist  ¿Àµ¿·Ä(¼º±Õ°ü´ë ¹æ»ç¼±Á¾¾çÇаú) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 16:00~16:20 Chemotherapy strategies according to histology and staging-Aspect from Oncologist  ±èÁö¿ø(¼­¿ï´ë Á¾¾ç³»°ú) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 16:20~16:40 Organ preservation in maxillectomies: when and how?  Á¤¿ë±â(¼º±Õ°ü´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ 16:40~17:00 Pearls and tips of maxillectomy-partial, total, radical procedures  À¯¸í»ó(¿ï»ê´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ08:40~09:05 Treatment and prognosis of anosmia/ageusia in post-Covid19 infection  ¼­¹Î¿µ(°í·Á´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ09:05~09:30 Covid19 in allergic rhintis and chronic rhinosinusitis  ÀÌÀºÁ¤(¿¬¼¼´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ09:30~09:55 Covid19 in obstructive sleep apnea  ±èÇöÁØ(¾ÆÁÖ´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ09:55~10:20 Guidelines and considerations for Covid19 vaccination when taking medication for Rhinologic disease  ÀÌÀç°©(ÇѸ²´ë °¨¿°³»°ú) 
È޽Ġ07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ10:20~10:40 Coffee Break  () 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ10:40~11:00 Dental implant in CRS: when to proceed and management - Aspect from Oral and Maxillofacial Surgeon  ±Ç¿ë´ë(°æÈñ´ë ±¸°­¾Ç¾È¸é¿Ü°ú) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ11:00~11:20 CRS treatment for dental implant: when to proceed ? - Aspect from Rhinologist  Á¤ÁøÇõ(ÇѾç´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ11:20~11:40 What are the favorable predictors of MAD in severe OSA?  ¹ÚÂù¼ø(°¡Å縯´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ11:40~12:00 Realworld and future of MAD for OSA  ±è¼ºÅÃ(¿¬¼¼´ë ±¸°­³»°ú) 
½Ä»ç 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ12:00~12:30 Luncheon symposium  () 
½Ä»ç 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ12:30~13:30 Lunch  () 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ13:30~13:55 Structure preservation rhinoplasty for dorsal hump  ÁøÈ«·ü(´ÚÅÍÁøÀ̺ñÀÎÈÄ°ú) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ13:55~14:20 Realworld and essential techniques of nasal valve surgery  ÃÖÁöÀ±(Á¶¼±´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ14:20~14:45 Caudal septal deviation-How I do it  ¹ÚÀÏÈ£(°í·Á´ë) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ14:45~15:10 Pearls and tips of ECRS surgery and perioperative management  ±è°æ¼ö(Áß¾Ó´ë) 
È޽Ġ07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ15:10~15:40 Coffee Break  () 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ15:40~16:00 In Primary ciliary dyskinesia (PCD)  ¿ÀÁö¿µ(¿¬¼¼´ë ÀÓ»óÀ¯Àü°ú) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ16:00~16:20 In Primary Immunodeficiency (PID)  ±è¿¹Áø(¼º±Õ°ü´ë ¼Ò¾Æ°ú) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ16:20~16:40 In Granulomatosis with polyangitis (GPA)  ÀÌ»ó¿ø(¿¬¼¼´ë ·ù¸¶Æ¼½º³»°ú) 
±³À°½Ã°£ 07-25 ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼Ç¼¾ÅÍ ´ëȸÀǽǠ16:40~17:00 In Aspirin exacerbated respiratory disease (AERD)  Á¶±Ô¼·(ºÎ»ê´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2021 ´ëÇѺñ°úÇÐȸ Çмú½ÉÆ÷Áö¾ö : 2021-07-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2021 Á¦20ȸ ´ëÇѾȰúÀÇ»çȸ Á¤±âÇмú´ëȸ(2ÀÏÂ÷) : 2021-07-25
´ÙÀ½±Û ´ëÇѺ´¸®ÇÐȸ (¿Â¶óÀÎ)2021³âµµ Á¦2Â÷ ¿¬¼ö±³À°(½ÅÀ庴¸®) : 2021-07-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20679 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦2Â÷¿¬¼ö±³À°(Ç÷°üÁúȯ, À̽ļö¼ú) : 2024-06-13 0 29 2024-05-10
20678 ¼­¿ï ±¸·Î±¸ÀÇ»çȸ 2024³âµµ Á¦2Â÷ ¿¬¼ö±³À° : 2024-06-11 0 31 2024-05-10
20677 ¼­¿ï ´ëÇѼҾƽÅÀåÇÐȸ (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-06-10 0 39 2024-05-10
20676 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼ÒÈ­±â³»°ú ºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-09 0 45 2024-05-10
20675 Ãæ³² 2024³â »ó¹Ý±â ´ëÇÑÁßȯÀÚÀÇÇÐȸ ´ëÀü¼¼Á¾ÃæûÁöȸ ¿¬¼ö±³À° : 2024-06-08 0 20 2024-05-10
20674 ºÎ»ê 2024³â Á¦ 7ȸ ´ëÇÑÁßȯÀÚÀÇÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2024-06-08 0 15 2024-05-10
20673 ´ë±¸ Á¦24Â÷ ´ë±¸°æºÏ ´ç´¢º´ ±³À°ÀÚ ¿¬¼ö°­Á : 2024-06-08 0 28 2024-05-10
20672 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 1Â÷ : 2024-06-08 0 13 2024-05-10
20671 ¼­¿ï »ï¼º¼­¿ïº´¿ø ÈäºÎ¿Ü°ú SMC MCS Symposium 2024 : 2024-06-08 0 18 2024-05-10
20670 ¼­¿ï 2024 ´ëÇѵðÁöÅÐÀÓ»óÀÇÇÐȸ ÇÏ°è Çмú´ëȸ : 2024-06-02 0 19 2024-05-10
20669 ¼­¿ï Á¦6ȸ ´ëÇѼö¼úÁ߽Űæ°è°¨½ÃÇÐȸ ¿¬¼ö°­Á : 2024-06-01 0 13 2024-05-10
20668 ºÎ»ê ±¸Á¶½ÉÁúȯ¿¬±¸È¸ The 7th K-SCI(Korea Structural Cardiovascular Intervention) Symposium : 2024-06-01 0 20 2024-05-10
20667 ±¤ÁÖ ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ 2024³â ÇÁ·ÎÆ÷Æú ÁøÁ¤±³À° : 2024-06-01 0 13 2024-05-10
20666 ´ëÀü 2024³â ´ëÇÑ°¡Á¤ÀÇÇÐȸ ´ëÀü¼¼Á¾Áöȸ Ãá°èÇмú´ëȸ(°íÇ÷¾Ð, °ú¹Î¼º ÀåÁõÈıº, ¼ö¸éÀå¾Ö) : 2024-05-30 0 19 2024-05-10
20665 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø ºñ´¢ÀÇÇаú ¿¬¼ö°­Á : 2024-05-30 0 36 2024-05-10
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷